OBJECTIVE: The Brief Pain Inventory (BPI) was designed to yield separate scores for pain intensity and interference. It has been proposed that the pain interference factor can be further broken down into unique factors of affective (e.g., mood) and activity (e.g., work) interference. The purpose of this analysis was to confirm this affective/activity interference dichotomy. PATIENTS AND METHODS: A retrospective confirmatory factor analysis was completed for a sample of 184 individuals diagnosed with castrate-resistant prostate cancer (age 40-86, mean = 65.46, 77% White non-Hispanic) who had been administered the BPI as part of Cancer and Leukemia Group B trial 9480. A one-factor model was compared against two-factor and three-factor models that were developed based on the design of the instrument. RESULTS: Root mean squared error of approximation (0.075), comparative fit index (0.971), and change in chi-square, given the corresponding change in degrees of freedom (13.33, P < 0.05) values for the three-factor model (i.e., pain intensity, activity interference, and affective interference), were statistically superior in comparison with the one- and two-factor models. This three-factor structure was found to be invariant across age, mean prostate-specific antigen, and hemoglobin levels. CONCLUSIONS: These results confirm that the BPI can be used to quantify the degree to which pain separately interferes with affective and activity aspects of a patient's everyday life. These findings will provide clinical trialists, pharmaceutical sponsors, and regulators with confidence in the flexibility of the BPI as they consider the use of this instrument to assist with understanding the patient experience as it relates to treatment. Wiley Periodicals, Inc.
RCT Entities:
OBJECTIVE: The Brief Pain Inventory (BPI) was designed to yield separate scores for pain intensity and interference. It has been proposed that the pain interference factor can be further broken down into unique factors of affective (e.g., mood) and activity (e.g., work) interference. The purpose of this analysis was to confirm this affective/activity interference dichotomy. PATIENTS AND METHODS: A retrospective confirmatory factor analysis was completed for a sample of 184 individuals diagnosed with castrate-resistant prostate cancer (age 40-86, mean = 65.46, 77% White non-Hispanic) who had been administered the BPI as part of Cancer and Leukemia Group B trial 9480. A one-factor model was compared against two-factor and three-factor models that were developed based on the design of the instrument. RESULTS: Root mean squared error of approximation (0.075), comparative fit index (0.971), and change in chi-square, given the corresponding change in degrees of freedom (13.33, P < 0.05) values for the three-factor model (i.e., pain intensity, activity interference, and affective interference), were statistically superior in comparison with the one- and two-factor models. This three-factor structure was found to be invariant across age, mean prostate-specific antigen, and hemoglobin levels. CONCLUSIONS: These results confirm that the BPI can be used to quantify the degree to which pain separately interferes with affective and activity aspects of a patient's everyday life. These findings will provide clinical trialists, pharmaceutical sponsors, and regulators with confidence in the flexibility of the BPI as they consider the use of this instrument to assist with understanding the patient experience as it relates to treatment. Wiley Periodicals, Inc.
Authors: Thomas M Atkinson; Tito R Mendoza; Laura Sit; Steven Passik; Howard I Scher; Charles Cleeland; Ethan Basch Journal: Pain Med Date: 2010-01-15 Impact factor: 3.750
Authors: Travis L Osborne; Katherine A Raichle; Mark P Jensen; Dawn M Ehde; George Kraft Journal: J Pain Symptom Manage Date: 2006-09 Impact factor: 3.612
Authors: Thomas M Atkinson; Barry D Rosenfeld; Laura Sit; Tito R Mendoza; Mike Fruscione; Dawn Lavene; Mary Shaw; Yuelin Li; Jennifer Hay; Charles S Cleeland; Howard I Scher; William S Breitbart; Ethan Basch Journal: J Pain Symptom Manage Date: 2010-12-04 Impact factor: 3.612
Authors: Svetlana A Kalyadina; Tatyana I Ionova; Maria O Ivanova; Olga S Uspenskaya; Anton V Kishtovich; Tito R Mendoza; Hong Guo; Andrei Novik; Charles S Cleeland; Xin S Wang Journal: J Pain Symptom Manage Date: 2007-11-05 Impact factor: 3.612
Authors: Susan Halabi; Nicholas J Vogelzang; Alice B Kornblith; San-San Ou; Philip W Kantoff; Nancy A Dawson; Eric J Small Journal: J Clin Oncol Date: 2008-05-20 Impact factor: 44.544
Authors: Alexandra D Frolkis; Jennifer de Bruyn; Nathalie Jette; Mark Lowerison; Jordan Engbers; William Ghali; James D Lewis; Isabelle Vallerand; Scott Patten; Bertus Eksteen; Cheryl Barnabe; Remo Panaccione; Subrata Ghosh; Samuel Wiebe; Gilaad G Kaplan Journal: Clin Transl Gastroenterol Date: 2016-04-21 Impact factor: 4.488